SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on April 10, 2003; DOI 10.1182/blood-2002-11-3355. This Article Full Text Full Text (PDF) All Versions of this Article: 2002-11-3355v1 102/3/956    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bourke, E. Articles by Mantovani, A. Search for Related Content PubMed PubMed Citation Articles by Bourke, E. Articles by Mantovani, A. Related Collections Immunobiology Neoplasia Gene Expression Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 August 2003, Vol. 102, No. 3, pp. 956-963 IMMUNOBIOLOGY The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells Emer Bourke, Daniela Bosisio, Josée Golay, Nadia Polentarutti, and Alberto Mantovani From the Department of Immunology and Cell Biology, Mario Negri Institute; and the Centro IDET Istituto di Patologia Generale, Università di Milano, Milan, Italy The present study was designed to investigate the expression of members of the toll-like receptor (TLR) family in human B cells. High-density, resting, and low-density activated tonsillar B cells expressed TLR9 and TLR10 mRNA transcripts at the highest levels. Expression was higher in activated B cells than in resting cells. Analysis of a range of resting and activated human leukocyte populations revealed that mRNA expression of TLR10 was restricted to B cells. Stimulation of resting B cells with anti-µ and anti-CD40 antibodies or with Staphylococcus aureus Cowan I bacteria (SAC) increased expression of TLR9 and TLR10. TLR1 and TLR4 expression were not significantly induced by B-cell activation. Interestingly, a CpG oligonucleotide, a TLR9 agonist, also stimulated TLR9 expression in B cells. Exposure to anti-µ antibodies augmented TLR9 expression, concomitantly and dramatically increasing the responsiveness of B cells to CpG oligonucleotides in terms of proliferation and chemokine (CC chemokine ligand 3 [CCL3] and CCL22) production. Epstein-Barr virus (EBV)–transformed cell lines and other cell lines representative of mature B-cell neoplasias (Burkitt lymphoma, follicular lymphoma, multiple myeloma) expressed TLR9 and/or TLR10, whereas pre-B cell lines were negative. These results show that normal and neoplastic human B lymphocytes express a distinct TLR repertoire including TLR9 and TLR10 and that expression is increased upon engagement of the antigen receptor complex or TLR9 itself. Regulated expression of selected TLRs in B cells is likely to play an important role in linking innate and adaptive immune responses in normal and pathologic conditions. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: A. M. Didierlaurent, S. Morel, L. Lockman, S. L. Giannini, M. Bisteau, H. Carlsen, A. Kielland, O. Vosters, N. Vanderheyde, F. Schiavetti, et al. AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity J. Immunol., November 15, 2009; 183(10): 6186 - 6197. [Abstract] [Full Text] [PDF] J. S. Poovassery, T. J. Vanden Bush, and G. A. Bishop Antigen Receptor Signals Rescue B Cells from TLR Tolerance J. Immunol., September 1, 2009; 183(5): 2974 - 2983. [Abstract] [Full Text] [PDF] L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora IFN-{alpha} amplifies human naive B cell TLR-9-mediated activation and Ig production J. Leukoc. Biol., August 1, 2009; 86(2): 261 - 271. [Abstract] [Full Text] [PDF] S. M. Gregory, J. A. West, P. J. Dillon, C. Hilscher, D. P. Dittmer, and B. Damania Toll-like receptor signaling controls reactivation of KSHV from latency PNAS, July 14, 2009; 106(28): 11725 - 11730. [Abstract] [Full Text] [PDF] V. Maina, A. Cotena, A. Doni, M. Nebuloni, F. Pasqualini, C. M. Milner, A. J. Day, A. Mantovani, and C. Garlanda Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6 J. Leukoc. Biol., July 1, 2009; 86(1): 123 - 132. [Abstract] [Full Text] [PDF] G. Chikh, S. D. de Jong, L. Sekirov, S. G. Raney, M. Kazem, K. D. Wilson, P. R. Cullis, J. P. Dutz, and Y. K. Tam Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles Int. Immunol., July 1, 2009; 21(7): 757 - 767. [Abstract] [Full Text] [PDF] J. Eckl-Dorna and F. D. Batista BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation Blood, April 23, 2009; 113(17): 3969 - 3977. [Abstract] [Full Text] [PDF] H. Shin, Y. Zhang, M. Jagannathan, H. Hasturk, A. Kantarci, H. Liu, T. E. Van Dyke, L. M. Ganley-Leal, and B. S. Nikolajczyk B cells from periodontal disease patients express surface Toll-like receptor 4 J. Leukoc. Biol., April 1, 2009; 85(4): 648 - 655. [Abstract] [Full Text] [PDF] I. Douagi, C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sorensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Lore Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells J. Immunol., February 15, 2009; 182(4): 1991 - 2001. [Abstract] [Full Text] [PDF] A. T. Vaughan, A. Gorringe, V. Davenport, N. A. Williams, and R. S. Heyderman Absence of Mucosal Immunity in the Human Upper Respiratory Tract to the Commensal Bacteria Neisseria lactamica but Not Pathogenic Neisseria meningitidis during the Peak Age of Nasopharyngeal Carriage J. Immunol., February 15, 2009; 182(4): 2231 - 2240. [Abstract] [Full Text] [PDF] M. P. Purdue, Q. Lan, S. S. Wang, A. Kricker, I. Menashe, T.-Z. Zheng, P. Hartge, A. E. Grulich, Y. Zhang, L. M. Morton, et al. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma Carcinogenesis, February 1, 2009; 30(2): 275 - 281. [Abstract] [Full Text] [PDF] K. L. Good, D. T. Avery, and S. G. Tangye Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells J. Immunol., January 15, 2009; 182(2): 890 - 901. [Abstract] [Full Text] [PDF] M. Pietropaolo, J. M. Surhigh, P. W. Nelson, and G. S. Eisenbarth Primer: Immunity and Autoimmunity Diabetes, November 1, 2008; 57(11): 2872 - 2882. [Full Text] [PDF] D. Chiron, I. Bekeredjian-Ding, C. Pellat-Deceunynck, R. Bataille, and G. Jego Toll-like receptors: lessons to learn from normal and malignant human B cells Blood, September 15, 2008; 112(6): 2205 - 2213. [Abstract] [Full Text] [PDF] J. F. Porter, S. Vavassori, and L. R. Covey A Polypyrimidine Tract-Binding Protein-Dependent Pathway of mRNA Stability Initiates with CpG Activation of Primary B Cells J. Immunol., September 1, 2008; 181(5): 3336 - 3345. [Abstract] [Full Text] [PDF] W. Jiang, M. M. Lederman, R. J. Mohner, B. Rodriguez, T. M. Nedrich, C. V. Harding, and S. F. Sieg Impaired Naive and Memory B-Cell Responsiveness to TLR9 Stimulation in Human Immunodeficiency Virus Infection J. Virol., August 15, 2008; 82(16): 7837 - 7845. [Abstract] [Full Text] [PDF] W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF J. Immunol., July 1, 2008; 181(1): 276 - 287. [Abstract] [Full Text] [PDF] D. B. Rosen, W. Cao, D. T. Avery, S. G. Tangye, Y.-J. Liu, J. P. Houchins, and L. L. Lanier Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells J. Immunol., May 15, 2008; 180(10): 6508 - 6517. [Abstract] [Full Text] [PDF] A. V. Rubtsov, C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres TLR Agonists Promote Marginal Zone B Cell Activation and Facilitate T-Dependent IgM Responses J. Immunol., March 15, 2008; 180(6): 3882 - 3888. [Abstract] [Full Text] [PDF] N. Fitzner, S. Clauberg, F. Essmann, J. Liebmann, and V. Kolb-Bachofen Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands Clin. Vaccine Immunol., January 1, 2008; 15(1): 138 - 146. [Abstract] [Full Text] [PDF] L. N. Fink, L. H. Zeuthen, H. R. Christensen, B. Morandi, H. Frokiaer, and G. Ferlazzo Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses Int. Immunol., December 1, 2007; 19(12): 1319 - 1327. [Abstract] [Full Text] [PDF] C. Grandjenette, A. Kennel, G. C. Faure, M. C. Bene, and P. Feugier Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells Haematologica, September 1, 2007; 92(9): 1279 - 1281. [Abstract] [Full Text] [PDF] J. B. Ewaschuk, J. L. Backer, T. A. Churchill, F. Obermeier, D. O. Krause, and K. L. Madsen Surface Expression of Toll-Like Receptor 9 Is Upregulated on Intestinal Epithelial Cells in Response to Pathogenic Bacterial DNA Infect. Immun., May 1, 2007; 75(5): 2572 - 2579. [Abstract] [Full Text] [PDF] A. Ertesvag, H.-C. Aasheim, S. Naderi, and H. K. Blomhoff Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK Blood, May 1, 2007; 109(9): 3865 - 3872. [Abstract] [Full Text] [PDF] S. Jaillon, G. Peri, Y. Delneste, I. Fremaux, A. Doni, F. Moalli, C. Garlanda, L. Romani, H. Gascan, S. Bellocchio, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps J. Exp. Med., April 16, 2007; 204(4): 793 - 804. [Abstract] [Full Text] [PDF] I. Bekeredjian-Ding, S. Inamura, T. Giese, H. Moll, S. Endres, A. Sing, U. Zahringer, and G. Hartmann Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands J. Immunol., March 1, 2007; 178(5): 2803 - 2812. [Abstract] [Full Text] [PDF] J. Huggins, T. Pellegrin, R. E. Felgar, C. Wei, M. Brown, B. Zheng, E. C. B. Milner, S. H. Bernstein, I. Sanz, and M. S. Zand CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells Blood, February 15, 2007; 109(4): 1611 - 1619. [Abstract] [Full Text] [PDF] K. E. Gunn and J. W. Brewer Evidence That Marginal Zone B Cells Possess an Enhanced Secretory Apparatus and Exhibit Superior Secretory Activity J. Immunol., September 15, 2006; 177(6): 3791 - 3798. [Abstract] [Full Text] [PDF] T. H. Mogensen, S. R. Paludan, M. Kilian, and L. Ostergaard Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns J. Leukoc. Biol., August 1, 2006; 80(2): 267 - 277. [Abstract] [Full Text] [PDF] F. Larousserie, P. Charlot, E. Bardel, J. Froger, R. A. Kastelein, and O. Devergne Differential Effects of IL-27 on Human B Cell Subsets J. Immunol., May 15, 2006; 176(10): 5890 - 5897. [Abstract] [Full Text] [PDF] E. Schlaepfer, A. Audige, H. Joller, and R. F. Speck TLR7/8 Triggering Exerts Opposing Effects in Acute versus Latent HIV Infection. J. Immunol., March 1, 2006; 176(5): 2888 - 2895. [Abstract] [Full Text] [PDF] C. Cunningham-Rundles, L. Radigan, A. K. Knight, L. Zhang, L. Bauer, and A. Nakazawa TLR9 Activation Is Defective in Common Variable Immune Deficiency J. Immunol., February 1, 2006; 176(3): 1978 - 1987. [Abstract] [Full Text] [PDF] I. N. Buhtoiarov, H. D. Lum, G. Berke, P. M. Sondel, and A. L. Rakhmilevich Synergistic Activation of Macrophages via CD40 and TLR9 Results in T Cell Independent Antitumor Effects J. Immunol., January 1, 2006; 176(1): 309 - 318. [Abstract] [Full Text] [PDF] X.-M. Chen, S. P. O'Hara, J. B. Nelson, P. L. Splinter, A. J. Small, P. S. Tietz, A. H. Limper, and N. F. LaRusso Multiple TLRs Are Expressed in Human Cholangiocytes and Mediate Host Epithelial Defense Responses to Cryptosporidium parvum via Activation of NF-{kappa}B J. Immunol., December 1, 2005; 175(11): 7447 - 7456. [Abstract] [Full Text] [PDF] J. M. Roda, R. Parihar, and W. E. Carson III CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells J. Immunol., August 1, 2005; 175(3): 1619 - 1627. [Abstract] [Full Text] [PDF] M. Hoogendoorn, J. Olde Wolbers, W. M. Smit, M. R. Schaafsma, I. Jedema, R. M.Y. Barge, R. Willemze, and J.H. F. Falkenburg Primary Allogeneic T-Cell Responses against Mantle Cell Lymphoma Antigen-Presenting Cells for Adoptive Immunotherapy after Stem Cell Transplantation Clin. Cancer Res., July 15, 2005; 11(14): 5310 - 5318. [Abstract] [Full Text] [PDF] G. S. D. Reid, K. She, L. Terrett, M. R. Food, J. D. Trudeau, and K. R. Schultz CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response Blood, May 1, 2005; 105(9): 3641 - 3647. [Abstract] [Full Text] [PDF] U. Hasan, C. Chaffois, C. Gaillard, V. Saulnier, E. Merck, S. Tancredi, C. Guiet, F. Briere, J. Vlach, S. Lebecque, et al. Human TLR10 Is a Functional Receptor, Expressed by B Cells and Plasmacytoid Dendritic Cells, Which Activates Gene Transcription through MyD88 J. Immunol., March 1, 2005; 174(5): 2942 - 2950. [Abstract] [Full Text] [PDF] K. U. Saikh, T. L. Kissner, A. Sultana, G. Ruthel, and R. G. Ulrich Human Monocytes Infected with Yersinia pestis Express Cell Surface TLR9 and Differentiate into Dendritic Cells J. Immunol., December 15, 2004; 173(12): 7426 - 7434. [Abstract] [Full Text] [PDF] A. Eaton-Bassiri, S. B. Dillon, M. Cunningham, M. A. Rycyzyn, J. Mills, R. T. Sarisky, and M. L. Mbow Toll-Like Receptor 9 Can Be Expressed at the Cell Surface of Distinct Populations of Tonsils and Human Peripheral Blood Mononuclear Cells Infect. Immun., December 1, 2004; 72(12): 7202 - 7211. [Abstract] [Full Text] [PDF] E. Schlaepfer, A. Audige, B. von Beust, V. Manolova, M. Weber, H. Joller, M. F. Bachmann, T. M. Kundig, and R. F. Speck CpG Oligodeoxynucleotides Block Human Immunodeficiency Virus Type 1 Replication in Human Lymphoid Tissue Infected Ex Vivo J. Virol., November 15, 2004; 78(22): 12344 - 12354. [Abstract] [Full Text] [PDF] R. Lazarus, B. A. Raby, C. Lange, E. K. Silverman, D. J. Kwiatkowski, D. Vercelli, W. J. Klimecki, F. D. Martinez, and S. T. Weiss TOLL-like Receptor 10 Genetic Variation Is Associated with Asthma in Two Independent Samples Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 594 - 600. [Abstract] [Full Text] [PDF] F. Takeshita, K. Suzuki, S. Sasaki, N. Ishii, D. M. Klinman, and K. J. Ishii Transcriptional Regulation of the Human TLR9 Gene J. Immunol., August 15, 2004; 173(4): 2552 - 2561. [Abstract] [Full Text] [PDF] S. Sivori, M. Falco, M. D. Chiesa, S. Carlomagno, M. Vitale, L. Moretta, and A. Moretta CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells PNAS, July 6, 2004; 101(27): 10116 - 10121. [Abstract] [Full Text] [PDF] H. Poeck, M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help Blood, April 15, 2004; 103(8): 3058 - 3064. [Abstract] [Full Text] [PDF] H.-J. Anders, B. Banas, and D. Schlondorff Signaling Danger: Toll-Like Receptors and their Potential Roles in Kidney Disease J. Am. Soc. Nephrol., April 1, 2004; 15(4): 854 - 867. [Abstract] [Full Text] [PDF]

	Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020